|
SIN3A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.17320000000165E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.296480E-02 |
| Normal-vs-Stage2 |
3.616700E-04 |
| Normal-vs-Stage3 |
3.37809999972905E-07 |
| Normal-vs-Stage4 |
1.63620000004361E-06 |
| Stage1-vs-Stage2 |
5.123600E-02 |
| Stage1-vs-Stage3 |
3.573300E-04 |
| Stage1-vs-Stage4 |
8.166800E-04 |
| Stage2-vs-Stage3 |
5.057200E-01 |
| Stage2-vs-Stage4 |
4.152200E-01 |
| Stage3-vs-Stage4 |
7.850000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.13949999999996E-05 |
| Normal-vs-AfricanAmerican |
1.660120E-03 |
| Normal-vs-Asian |
2.973200E-01 |
| Caucasian-vs-AfricanAmerican |
6.628800E-01 |
| Caucasian-vs-Asian |
6.660200E-01 |
| AfricanAmerican-vs-Asian |
6.089800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.01639999999992E-06 |
| Normal-vs-Female |
5.015500E-03 |
| Male-vs-Female |
2.693700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.416500E-03 |
| Normal-vs-Age(41-60Yrs) |
7.228600E-04 |
| Normal-vs-Age(61-80Yrs) |
5.50059999999686E-05 |
| Normal-vs-Age(81-100Yrs) |
1.035670E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.426600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.395800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.599800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.808200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.268640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.873000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.135200E-01 |
| Normal-vs-Grade 2 |
2.700300E-02 |
| Normal-vs-Grade 3 |
1.12269999963388E-07 |
| Normal-vs-Grade 4 |
1.68799999533675E-08 |
| Grade 1-vs-Grade 2 |
2.366000E-02 |
| Grade 1-vs-Grade 3 |
1.160380E-04 |
| Grade 1-vs-Grade 4 |
1.54670999999995E-05 |
| Grade 2-vs-Grade 3 |
5.93329999999392E-05 |
| Grade 2-vs-Grade 4 |
1.81928999999359E-05 |
| Grade 3-vs-Grade 4 |
1.263640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.192780E-01 |
| Normal-vs-ccB subtype |
7.26140000018027E-07 |
| ccA subtype-vs-ccB subtype |
4.90669999964055E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.167340E-04 |
| Normal-vs-N1 |
1.055790E-02 |
| N0-vs-N1 |
4.959600E-01 |
|
|
